Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last A$2.39 AUD
Change Today +0.03 / 1.27%
Volume 5.3K
As of 12:04 AM 10/9/15 All times are local (Market data is delayed by at least 15 minutes).

somnomed ltd (SOM) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/20/15 - A$3.20
52 Week Low
10/14/14 - A$2.13
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SOMNOMED LTD (SOM)

Related News

No related news articles were found.

somnomed ltd (SOM) Related Businessweek News

No Related Businessweek News Found

somnomed ltd (SOM) Details

SomnoMed Limited produces and sells devices for the oral treatment of sleep related disorders primarily in the Asia Pacific, Europe, and the United States. The company provides diagnostic and treatment options for sleep-related breathing disorders, such as obstructive sleep apnea and sleep bruxism. Its products include SomnoDent oral appliances for obstructive sleep apnea; SomnoBrux products to protect patient’s teeth against heavy grinding; and DentiTrac compliance control systems, as well as SomTabs for cleaning its devices. The company was founded in 2004 and is based in Crows Nest, Australia.

300 Employees
Last Reported Date: 09/28/15
Founded in 2004

somnomed ltd (SOM) Top Compensated Officers

Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: A$320.0K
President of Somnomed Inc
Total Annual Compensation: A$477.8K
Vice President of Global Production and Produ...
Total Annual Compensation: A$180.0K
Vice President of Marketing and Sales Europe
Total Annual Compensation: A$287.8K
Compensation as of Fiscal Year 2015.

somnomed ltd (SOM) Key Developments

SomnoMed Limited Reports Unaudited Group Earnings Results for the Year Ended June 30, 2015; Provides Earnings Guidance for the Fiscal Year 2016

SomnoMed Limited reported unaudited group earnings results for the year ended June 30, 2015. For the year, the company’s total group revenue was AUD 34,438,000 against AUD 30,274,000 a year ago. Operating profit before corporate, research and business development expenses, other items of revenue expense and income tax was AUD 3,582,000 against AUD 3,698,000 a year ago. EBITDA was AUD 870,000 against AUD 1,050,000 a year ago. For the fiscal year 2016, the company expects MAS volume of 62,000 MAS units, total group revenues of AUD 42 million, MAS gross margin of 69% and EBITDA of AUD 3 million.

SomnoMed Limited Reports Sales Results for the Month, Third Quarter and Nine Months Ended March 2015

SomnoMed Limited reported sales results for the month, third quarter and nine months ended March 2015. The company total revenues grew by 17.3% to $7.62 million during third quarter of 2015. The third quarter of the financial year produced total sales of 12,063 SomnoDent® units and 9.6% above the same quarter in the previous year. For the nine months, the company reported revenue of $22.4 million, 17.8% higher than in the same period in the previous year. The month of March generated sales of 5,128 SomnoDent® units (an increase 24.5% over the prior year) and total revenues of $3.03 million (an increase 27.7% over the prior year).

SomnoMed Limited(ASX:SOM) added to S&P/ASX All Ordinaries Index

SomnoMed Limited(ASX:SOM) added to S&P/ASX All Ordinaries Index


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SOM:AU A$2.39 AUD +0.03

SOM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SOM.
View Industry Companies

Industry Analysis


Industry Average

Valuation SOM Industry Range
Price/Earnings 100.0x
Price/Sales 5.9x
Price/Book 5.4x
Price/Cash Flow 93.7x
TEV/Sales 3.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SOMNOMED LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at